Carlos Perez Lopez, MD
Infectious Disease · San Juan, PRNPI 1861810012
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 51 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Johnson & Johnson at 28.4% of the total. 2025 is the largest year on record at $323, 3.8 times the $86 reported in 2020.
Across 51 payments — averaging $25.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$368
- AbbVie$258
- Johnson And Johnson International$123
- Stryker$106
- AstraZeneca$100
- Amgen$99
- plus $241 from 7 others
What the payments were for
- Food & beverage$1,294100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 17 | $368 |
| AbbVie | 11 | $258 |
| Johnson And Johnson International | 2 | $123 |
| Stryker | 1 | $106 |
| AstraZeneca(2 entities) | 4 | $100 |
| Amgen | 5 | $99 |
| Genentech USA, Inc. | 3 | $80 |
| Adaptive Biotechnologies Corporation | 2 | $42 |
| Rigel Pharmaceuticals, Inc. | 2 | $34 |
| Sanofi-aventis U.S. LLC | 1 | $27 |
| Eli Lilly Export S.A. Puerto Rico Branch | 1 | $25 |
| Kadmon Pharmaceuticals LLC | 1 | $17 |
| Jazz Pharmaceuticals Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INSPACE$106
How this compares
$1,294 in reported general payments places this provider in the 65th percentile of 127 infectious disease providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Acyclovir | 161 | $5,448 |
| M-M-R Ii VaccineMeasles,mumps,rubella Vacc/Pf | 12 | $1,325 |
| ValacyclovirValacyclovir Hcl | 15 | $1,190 |
| Engerix-B AdultHepatitis B Virus Vaccine/Pf | 11 | $892 |
| IpolPoliomyelitis Vaccine, Killed | 15 | $851 |
| Levofloxacin | 11 | $91 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 16 | $74 |
Paid to pharmacies, not to this prescriber.
Other infectious disease in San Juan
- Vanessa Olivo EchavarrySan Juan$41K
- Angeles Rodriguez RosaSan Juan$27K
- Miguel Colon PerezSan Juan$12K
- Javier MoralesSan Juan$9K
- Mario LopezSan Juan$9K
- Armando Torres NievesSan Juan$4K
- Carmelo Santana-LopezSan Juan$4K
- Elba Arroyo CamunasSan Juan$3K
- Jonathan Ruiz GarciaSan Juan$3K
- Sandra Maldonado-RiveraSan Juan$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.